CN105434467A - 一种冻疮治疗剂及其生产方法 - Google Patents
一种冻疮治疗剂及其生产方法 Download PDFInfo
- Publication number
- CN105434467A CN105434467A CN201510899238.7A CN201510899238A CN105434467A CN 105434467 A CN105434467 A CN 105434467A CN 201510899238 A CN201510899238 A CN 201510899238A CN 105434467 A CN105434467 A CN 105434467A
- Authority
- CN
- China
- Prior art keywords
- powder
- chilblain
- therapeutic agent
- perniosis
- stone needle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000010445 Chilblains Diseases 0.000 title claims abstract description 41
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 title claims abstract description 10
- 229940124597 therapeutic agent Drugs 0.000 title claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 32
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000004575 stone Substances 0.000 claims abstract description 24
- 229910052709 silver Inorganic materials 0.000 claims abstract description 9
- 239000004332 silver Substances 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 239000002674 ointment Substances 0.000 claims description 8
- 229940099259 vaseline Drugs 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 3
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 208000025865 Ulcer Diseases 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000009724 venous congestion Effects 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0017—Wound healing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0034—Skin treatment
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Inorganic Chemistry (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
本发明公开了一种冻疮治疗剂及其生产方法，该冻疮治疗剂取下述重量配比的材料生产而成：银粉0.05-0.1%、砭石粉30-60%、磁铁粉40-70%。本发明冻疮治疗剂中的砭石，可发射极远红外线和超声波脉冲，磁石可加速血液流动，同时银有灭菌作用，该治疗剂涂抹或佩戴在患病部位，省力省时，不使用动力，容易实行；并且本发明冻疮治疗剂的材料环保安全、无副作用，对冻疮治疗者是一种较好的产品。
Description
技术领域
本发明涉及医药技术领域，特别是涉及一种冻疮治疗剂及其生产方法。
背景技术
寒冷是冻疮发病的主要原因，当冻疮患者的肢体在遇到寒冷（0-10℃以下）时，潮湿和冷暖急变时，局部小动脉发生收缩，动脉血管麻痹而扩张，静脉瘀血，局部血液循环不良而发病。患者自身皮肤湿度，末梢微血管畸形，自主性神经功能紊乱，营养不良，内分泌障碍等因素可能参与发病。缺乏锻炼，手足多汗潮湿，鞋袜过紧及户外低温下工作等因素也可致冻疮发生。以末梢血液循环不良者多见。常见损害为局限性瘀血性暗紫色红色***性红斑，境界不清，边缘呈鲜红色，表面紧张有光泽，质柔软，局部按压可褪色，去压后恢复，严重者发生水泡，破裂形成糜烂或溃疡。痒感明显，溃烂后疼痛，也有发生在女性股部的上述症状，但还见呈蓝色浸润性的斑，偶有继发性溃疡和合并毛囊性角栓。针对上述症状，医务工作者给予这些患者各种不同的治疗方法。如口服烟酰胺，硝苯地平等血管扩张及丹参与低分子右旋糖酐静滴等。局部治疗用氦-氖激光照射，或激光穴位照射等。对溃疡部位，用多磺酸粘多糖乳膏，维生素E软膏等，以及用中药浸泡等。这些治疗措施对上述冻疮有一定的治疗作用，但有的方法如内服不能直达患位，而达不到疗效，有的等全身性好转才显出疗效，患者往往等待很长时间。
发明内容
本发明的目的之一是克服现有技术的不足，提供一种以促进血压循环，针对溃疡感染为主，可使冻疮部位恢复正常表象，功能恢复较快的冻疮治疗剂。
为了解决上述技术问题，本发明所采用的技术方案是：
一种冻疮治疗剂，取下述重量配比的材料生产而成：银粉0.05-0.1%、砭石粉30-60%、磁铁粉40-70%。
上述冻疮治疗剂，优选的，以凡士林为载体制成软膏。
本发明的另一目的是提供上述冻疮治疗剂的生产方法。
一种冻疮治疗剂的生产方法，步骤如下：
步骤一：将银在80-100℃温度下细化处理，细化致1-3纳米得到银粉；
步骤二：将砭石在80-100℃温度下细化处理，细化致1-100纳米得到砭石粉；
步骤三：将磁铁在80-100℃温度下细化处理，过120目筛，得到磁铁粉；
步骤四：将步骤一得到的银粉、步骤二得到的砭石粉、步骤三得到的磁铁粉混合均匀后，加入上述原料重量95%-100%的无菌凡士林，混匀制得冻疮软膏剂。
本发明所用原材料及其功能如下：
银粉：银对微生物（细菌、病毒等）有特殊的消杀作用。据测定，十亿分之一毫克的银，可杀灭1升水中所有的活体。
砭石粉：含锶、钛、铬、锌等几十种对人体有益的微量元素和矿物元素及稀土类，可显著加快甲襞微循环的血流速度；其增加值达20％以上而且效果是持续的；砭石可发出2万-200赫兹的远红外线电磁波峰值9.8微米，远红外线对于血液循环和循环障碍引起的多种疾病均具有改善和预防作用；并能产生2万-200赫兹的超声波脉冲，穿透率为92.8％，在人体上刮擦一次的振动次数为4106次，无对人体有害元素、放射性元素，并且砭石的奇异能量场可循径而行，疏通经络。
磁铁粉：人的血液中有微量的铁成分，而磁铁对铁磁化、斥力、吸引力的作用下，加速血液流动，达到降低血压、活血化瘀的目的。
与现有技术先比，本发明的有益效果为：
本发明冻疮治疗剂中的砭石，可发射极远红外线和超声波脉冲，磁石可加速血液流动，同时银有灭菌作用，该治疗剂涂抹或佩戴在患病部位，省力省时，不使用动力，容易实行；并且本发明冻疮治疗剂的材料环保安全、无副作用，对冻疮治疗者是一种较好的产品。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案，但保护范围不被此限制。
实施例1一种冻疮治疗剂，取下述重量的材料生产而成：银粉0.2g、砭石粉30g、磁铁粉70g。
上述冻疮治疗剂的生产方法，步骤如下：
步骤一：将银在80℃温度下细化处理，细化致3纳米得到银粉；
步骤二：将砭石在80℃温度下细化处理，细化致100纳米得到砭石粉；
步骤三：将磁铁在80℃温度下细化处理，过120目筛，得到磁铁粉；
步骤四：将步骤一得到的银粉、步骤二得到的砭石粉、步骤三得到的磁铁粉混合均匀后，加入98g无菌凡士林，混匀制得含银0.1%的冻疮膏200g。
该实施例中的冻疮治疗剂银成分高，以治疗冻疮时提高灭菌功能为主，如冻疮部位发生溃疡，易被细菌感染或已被细菌感染，应以实施例1配方的冻疮膏治疗。
实施例2一种冻疮治疗剂，取下述重量的材料生产而成：银粉0.1g、砭石粉40g、磁铁粉60g。
上述冻疮治疗剂的生产方法，步骤如下：
步骤一：将银在100℃温度下细化处理，细化致3纳米得到银粉；
步骤二：将砭石在100℃温度下细化处理，细化致100纳米得到砭石粉；
步骤三：将磁铁在100℃温度下细化处理，过120目筛，得到磁铁粉；
步骤四：将步骤一得到的银粉、步骤二得到的砭石粉、步骤三得到的磁铁粉混合均匀后，加入99.9g无菌凡士林，混匀制得含银0.05%的冻疮软膏剂。
该实施例中冻疮部分未出现溃疡，但明显变得红肿或出现其他因血液流通不畅而出现的症状，采用实施例2中的冻疮治疗剂以加快血液流动为主。
Claims (5)
1.一种冻疮治疗剂，其特征在于：取下述重量配比的材料生产而成：银粉0.05-0.1%、砭石粉30-60%、磁铁粉40-70%。
2.一种冻疮治疗剂，其特征在于：取下述重量配比的材料生产而成：银粉0.2g、砭石粉30g、磁铁粉70g。
3.一种冻疮治疗剂，其特征在于：取下述重量配比的材料生产而成：银粉0.1g、砭石粉40g、磁铁粉60g。
4.根据权利要求1-3任一项所述的一种冻疮治疗剂，其特征在于：治疗剂以凡士林为载体制成软膏。
5.根据权利要求1所述的一种冻疮治疗剂的生产方法，其特征在于：步骤如下：
步骤一：将银在80-100℃温度下细化处理，细化致1-3纳米得到银粉；
步骤二：将砭石在80-100℃温度下细化处理，细化致1-100纳米得到砭石粉；
步骤三：将磁铁在80-100℃温度下细化处理，过120目筛，得到磁铁粉；
步骤四：将步骤一得到的银粉、步骤二得到的砭石粉、步骤三得到的磁铁粉混合均匀后，加入上述原料重量95%-100%的无菌凡士林，混匀制得冻疮软膏剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510899238.7A CN105434467A (zh) | 2015-12-09 | 2015-12-09 | 一种冻疮治疗剂及其生产方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510899238.7A CN105434467A (zh) | 2015-12-09 | 2015-12-09 | 一种冻疮治疗剂及其生产方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105434467A true CN105434467A (zh) | 2016-03-30 |
Family
ID=55545401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510899238.7A Pending CN105434467A (zh) | 2015-12-09 | 2015-12-09 | 一种冻疮治疗剂及其生产方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105434467A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105878273A (zh) * | 2016-04-21 | 2016-08-24 | 武汉时代珍传医疗器械有限公司 | 一种耳穴压豆及其制备方法 |
| CN108175949A (zh) * | 2018-01-09 | 2018-06-19 | 山东权科生物技术有限公司 | 一种理疗材料及其制备方法 |
| CN110772530A (zh) * | 2019-12-18 | 2020-02-11 | 和也健康科技有限公司 | 一种活血组合物以及防护指套 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1308940A (zh) * | 2000-11-28 | 2001-08-22 | 高翠霞 | 一种纳米生物药石粉末的用途与生产方法 |
| CN1480045A (zh) * | 2003-07-21 | 2004-03-10 | 艳 林 | 广谱抗杀菌纳米软膏剂 |
| CN202437982U (zh) * | 2012-02-23 | 2012-09-19 | 刘帆 | 一种防治痔疮的外用药包 |
-
2015
- 2015-12-09 CN CN201510899238.7A patent/CN105434467A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1308940A (zh) * | 2000-11-28 | 2001-08-22 | 高翠霞 | 一种纳米生物药石粉末的用途与生产方法 |
| CN1480045A (zh) * | 2003-07-21 | 2004-03-10 | 艳 林 | 广谱抗杀菌纳米软膏剂 |
| CN202437982U (zh) * | 2012-02-23 | 2012-09-19 | 刘帆 | 一种防治痔疮的外用药包 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105878273A (zh) * | 2016-04-21 | 2016-08-24 | 武汉时代珍传医疗器械有限公司 | 一种耳穴压豆及其制备方法 |
| CN108175949A (zh) * | 2018-01-09 | 2018-06-19 | 山东权科生物技术有限公司 | 一种理疗材料及其制备方法 |
| CN108175949B (zh) * | 2018-01-09 | 2019-09-20 | 山东权科生物技术有限公司 | 一种理疗材料及其制备方法 |
| CN110772530A (zh) * | 2019-12-18 | 2020-02-11 | 和也健康科技有限公司 | 一种活血组合物以及防护指套 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI352597B (en) | Composition having effect of moxibustion and press | |
| CN103393916B (zh) | 一种治疗皮炎的外用药膏及制备方法 | |
| CN103446308A (zh) | 一种治疗脚底老茧的中药 | |
| CN103007153A (zh) | 一种保健型中药香囊 | |
| CN103007147A (zh) | 用于预防流感的中药香囊 | |
| CN103070996A (zh) | 用于防治流感的中药香囊 | |
| CN105434467A (zh) | 一种冻疮治疗剂及其生产方法 | |
| CN102988859A (zh) | 一种中药香囊 | |
| CN106075000A (zh) | 一种中药痔疮软膏及其制备方法 | |
| CN100393332C (zh) | 消肿拔毒生肌膏 | |
| CN104623432B (zh) | 一种***的中药组合物 | |
| CN103007155A (zh) | 用于防治感冒的中药香囊 | |
| CN105477446A (zh) | 一种治疗扁平疣的中药组合物 | |
| CN103006940A (zh) | 用于预防流感的中药香囊 | |
| CN109700844A (zh) | 一种治疗疔毒的外用药及其制备方法 | |
| CN104257777B (zh) | 一种治疗鼻炎、鼻窦炎、额窦炎的中药组合物及其制备方法 | |
| CN103006733A (zh) | 用于预防流感的中药香囊 | |
| CN102512650A (zh) | 一种治疗面神经***外用药物 | |
| CN106728069A (zh) | 一种治疗烫烧伤的祛腐生肌膏 | |
| CN104958653A (zh) | 一种治疗结核病的中药组合物 | |
| CN104027391A (zh) | 一种治疗汗斑的中药洗剂 | |
| Axe et al. | The Essential Oils Home Remedy Guide | |
| CN103006778A (zh) | 用于防治感冒的中药香囊 | |
| CN103007128A (zh) | 一种保健型中药香囊 | |
| CN102988472B (zh) | 一种治疗酒糟鼻的中药外用擦剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160330 |